|  | n(%) |
---|---|---|
1 | Incubation time for virus is 14–28 days | 337 (83.4%) |
2 | Antibiotics are the first line treatment for the management of MERS-CoV | 176 (43.6%) |
3 | Polymerase chain reaction can be used to diagnose MERS-CoV | 163 (40.3%) |
4 | Washing hands vigorously (soap/water) for 20 s helps in prevention/transmission of disease | 130 (32.2%) |
5 | Vaccination of MERS-CoV is available in market | 98 (24.3%) |
6 | MERS-CoV is caused by alpha coronavirus | 95 (23.5%) |
7 | The main source of MERS virus is plant | 86 (21.3%) |
8 | Transmission of MERS-CoV infection can be prevented by using universal precautions. | 82 (20.3%) |
9 | MERS patients should be kept in isolation | 78 (19.3%) |
10 | Gowns, gloves, mask and goggles must be used when dealing with MERS patients | 75 (18.6%) |
11 | People with co-morbidities are more likely to be infected | 73 (18.1%) |
12 | Special caution must be taken if a person presents with MERS symptoms from the Arabian Peninsula | 72 (17.8%) |
13 | MERS-CoV patients develop severe acute respiratory illness | 61 (15.1%) |
14 | MERS-CoV spreads through close contact like caring and/or living with infected persons | 54 (13.4%) |
15 | Fever, cough and shortage of breath are hallmark symptoms of MERS-CoV | 47 (11.6%) |
16 | MERS-CoV can be fatal | 47 (11.6%) |